Functions and consequences of AID/APOBEC-mediated DNA and RNA deamination
2022; Nature Portfolio; Volume: 23; Issue: 8 Linguagem: Inglês
10.1038/s41576-022-00459-8
ISSN1471-0064
AutoresRiccardo Pecori, Salvatore Di Giorgio, Jose Paulo Lorenzo, F. Nina Papavasiliou,
Tópico(s)Virus-based gene therapy research
ResumoThe AID/APOBEC polynucleotide cytidine deaminases have historically been classified as either DNA mutators or RNA editors based on their first identified nucleic acid substrate preference. DNA mutators can generate functional diversity at antibody genes but also cause genomic instability in cancer. RNA editors can generate informational diversity in the transcriptome of innate immune cells, and of cancer cells. Members of both classes can act as antiviral restriction factors. Recent structural work has illuminated differences and similarities between AID/APOBEC enzymes that can catalyse DNA mutation, RNA editing or both, suggesting that the strict functional classification of members of this family should be reconsidered. As many of these enzymes have been employed for targeted genome (or transcriptome) editing, a more holistic understanding will help improve the design of therapeutically relevant programmable base editors. In this Perspective, Pecori et al. provide an overview of the AID/APOBEC cytidine deaminase family, discussing key structural features, how they contribute to viral and tumour evolution and how they can be harnessed for (potentially therapeutic) base-editing purposes.
Referência(s)